Safety and clinical outcome of erythropoiesis-stimulating agents in patients with ST-elevation myocardial infarction: a meta-analysis of individual patient data.

MLA

Fokkema, Marieke L., et al. “Safety and Clinical Outcome of Erythropoiesis-Stimulating Agents in Patients with ST-Elevation Myocardial Infarction: A Meta-Analysis of Individual Patient Data.” American Heart Journal, vol. 168, no. 3, Sept. 2014, p. 354. EBSCOhost, https://doi.org/10.1016/j.ahj.2014.04.020.

APA

Fokkema, M. L., van der Meer, P., Rao, S. V., Belonje, A. M., Ferrario, M., Hillege, H. L., Katz, S. D., Lipšic, E., Ludman, A. J., Ott, I., Prunier, F., Choi, D.-J., Toba, K., van Veldhuisen, D. J., & Voors, A. A. (2014). Safety and clinical outcome of erythropoiesis-stimulating agents in patients with ST-elevation myocardial infarction: a meta-analysis of individual patient data. American Heart Journal, 168(3), 354. https://doi.org/10.1016/j.ahj.2014.04.020

Chicago

Fokkema, Marieke L, Peter van der Meer, Sunil V Rao, Anne M Belonje, Maurizio Ferrario, Hans L Hillege, Stuart D Katz, et al. 2014. “Safety and Clinical Outcome of Erythropoiesis-Stimulating Agents in Patients with ST-Elevation Myocardial Infarction: A Meta-Analysis of Individual Patient Data.” American Heart Journal 168 (3): 354. doi:10.1016/j.ahj.2014.04.020.